Esperion Therapeutics
ESPR
#6506
Rank
A$1.23 B
Marketcap
A$4.80
Share price
0.00%
Change (1 day)
27.69%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Last known market cap: A$1.23 Billion

As of November 2026 Esperion Therapeutics has a market cap of A$1.23 Billion. This makes Esperion Therapeutics the world's 6506th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$1.23 B-13.42%
2025A$1.42 B97.98%
2024A$0.72 B44.72%
2023A$0.49 B-26.02%
2022A$0.67 B60.61%
2021A$0.42 B-52.07%
2020A$0.87 B-62.58%
2019A$2.34 B33.71%
2018A$1.75 B-20.72%
2017A$2.20 B463.99%
2016A$0.39 B-43.06%
2015A$0.68 B-31.56%
2014A$1.00 B325.39%
2013A$0.23 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$235.95 B 18,958.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$143.89 B 11,522.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$2.53 B 104.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A$1.02 B-16.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$6.87 B 455.22%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$17.67 B 1,327.90%๐Ÿ‡บ๐Ÿ‡ธ USA